Arnais, Raisyl .

HRN: 23-64-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
AMPICILLIN 1GM (VIAL)
09/02/2023
09/03/2023
IV
2g
Q6h
PROM
Waiting Final Action 
09/02/2023
CO-AMOXICLAV 625MG (TAB)
09/02/2023
09/08/2023
PO
625mg
BID
PROM; S/p RMLE + Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: